Comparison of trimethoprim-sulfamethoxazole, cephadroxil and cefprozil as prophylaxis for recurrent urinary tract infections in children. 2004

N Belet, and I Işlek, and U Belet, and A T Sunter, and S Küçüködük
Ondokuz Mayis University, Faculty of Medicine, Department of Pediatrics, Samsun, Turkey. nursenbelet@hotmail.com

The aim of this study was to compare the efficacy of prophylactic trimethoprim-sulfamethoxazole (TMP/SMZ), cefprozil and cephadroxil treatments in children who have recurrent urinary tract infection, but no urinary tract pathology. After acute urinary tract infections (UTIs) were treated, the patients were divided into 3 groups randomly and TMP/SMZ was given to 21 patients, cephadroxil was given to 25 patients and cefprozil was given to 34 patients for 3 months--one dose at night. All patients were followed for 6 months following prophylaxis. The frequency of symptomatic UTIs among groups during prophylaxis was not statistically different, however the number of symptomatic UTIs in the cephadroxil group was lower than the other groups. Asymptomatic bacteriuria episodes were detected in TMP/SMZ and cefprozil groups, whereas no asymptomatic bacteriuria episodes were seen in the cephadroxil group. The number of patients with symptomatic UTI during the follow-up period was not different between groups, however all the asymptomatic bacteriuria episodes were encountered in the cefprozil group. In conclusion, in this study cephadroxil was found to be slightly superior to TMP/SMZ and cefprozil in preventing asymptomatic bacteriuria episodes and symptomatic UTIs in children with recurrent UTI and normal urinary tract system.

UI MeSH Term Description Entries
D008297 Male Males
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D002434 Cefadroxil Long-acting, broad-spectrum, water-soluble, CEPHALEXIN derivative. 4-Hydroxycephalexin,5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((amino(4-hydroxyphenyl)acetyl)amino)-3-methyl-8-oxo-, (6R-(6alpha,7beta(R*)))-,BL-S 578,BL-S578,Bidocef,Cefadroxil Anhydrous,Cefadroxil Monohydrate,Cephadroxyl,Duricef,S-578,S578,Ultracef,4 Hydroxycephalexin,BL S 578,BL S578,BLS 578,BLS578,S 578
D002511 Cephalosporins A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid. Antibiotics, Cephalosporin,Cephalosporanic Acid,Cephalosporin,Cephalosporin Antibiotic,Cephalosporanic Acids,Acid, Cephalosporanic,Acids, Cephalosporanic,Antibiotic, Cephalosporin,Cephalosporin Antibiotics
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000097670 Cefprozil A second-generation cephalosporin antibacterial agent. Cefprozil has a phenyl ring at the C-3 position of its cephalosporin core. Cefprozil Monohydrate,Cefprozil Sulfate,Arzimol,BMY 28100,BMY-28100,Brisoral,Cefzil,Procef,28100, BMY,Monohydrate, Cefprozil,Sulfate, Cefprozil
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations

Related Publications

N Belet, and I Işlek, and U Belet, and A T Sunter, and S Küçüködük
June 1975, Canadian Medical Association journal,
N Belet, and I Işlek, and U Belet, and A T Sunter, and S Küçüködük
January 2012, Archives of internal medicine,
N Belet, and I Işlek, and U Belet, and A T Sunter, and S Küçüködük
November 1978, American journal of diseases of children (1960),
N Belet, and I Işlek, and U Belet, and A T Sunter, and S Küçüködük
November 1973, The Journal of infectious diseases,
N Belet, and I Işlek, and U Belet, and A T Sunter, and S Küçüködük
December 1975, The Medical letter on drugs and therapeutics,
N Belet, and I Işlek, and U Belet, and A T Sunter, and S Küçüködük
November 1973, The Journal of infectious diseases,
N Belet, and I Işlek, and U Belet, and A T Sunter, and S Küçüködük
May 2009, The Journal of emergency medicine,
N Belet, and I Işlek, and U Belet, and A T Sunter, and S Küçüködük
April 2019, The Pediatric infectious disease journal,
N Belet, and I Işlek, and U Belet, and A T Sunter, and S Küçüködük
January 1979, Infection,
N Belet, and I Işlek, and U Belet, and A T Sunter, and S Küçüködük
September 2020, The Journal of urology,
Copied contents to your clipboard!